| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,048 |
2,536 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
358 |
349 |
$265.89 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
205 |
191 |
$18.10 |
| 3074F |
|
697 |
640 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,325 |
1,278 |
$0.00 |
| 85027 |
|
399 |
383 |
$0.00 |
| 83550 |
|
83 |
83 |
$0.00 |
| 3044F |
|
328 |
327 |
$0.00 |
| 81001 |
|
374 |
351 |
$0.00 |
| 99441 |
|
60 |
57 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
6,467 |
5,646 |
$0.00 |
| 82728 |
|
78 |
78 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,725 |
2,573 |
$0.00 |
| 82043 |
|
524 |
518 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
931 |
920 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,744 |
2,594 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,319 |
3,283 |
$0.00 |
| 3079F |
|
160 |
152 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
94 |
94 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
825 |
812 |
$0.00 |
| 3075F |
|
235 |
228 |
$0.00 |
| 1220F |
|
233 |
225 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
220 |
220 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
52 |
43 |
$0.00 |
| 1111F |
|
256 |
233 |
$0.00 |
| 90656 |
|
23 |
23 |
$0.00 |
| 90686 |
|
135 |
135 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
24 |
24 |
$0.00 |
| D1330 |
|
16 |
15 |
$0.00 |
| 87340 |
|
79 |
79 |
$0.00 |
| 84153 |
|
12 |
12 |
$0.00 |
| 99442 |
|
767 |
724 |
$0.00 |
| 82274 |
|
599 |
599 |
$0.00 |
| 80076 |
|
451 |
445 |
$0.00 |
| 80061 |
Lipid panel |
3,007 |
2,980 |
$0.00 |
| 85610 |
|
184 |
150 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,078 |
2,718 |
$0.00 |
| 82540 |
|
524 |
518 |
$0.00 |
| 91300 |
|
93 |
92 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
153 |
153 |
$0.00 |
| 83540 |
|
97 |
97 |
$0.00 |
| 3077F |
|
223 |
195 |
$0.00 |
| 86703 |
|
271 |
268 |
$0.00 |
| 90658 |
|
48 |
48 |
$0.00 |
| 77062 |
|
12 |
12 |
$0.00 |
| 3078F |
|
916 |
816 |
$0.00 |
| 3046F |
|
12 |
12 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
37 |
37 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
37 |
37 |
$0.00 |
| 81003 |
|
40 |
37 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
17 |
12 |
$0.00 |